Sunscreen myths, controversies continue

At the end of the day, "the best sunscreen is the one a patient will use regularly and actually enjoy using."

Expert shares key facts about keloid therapy

Management of keloids after excision is mainly based on anecdotal evidence

COVID-19 risks in rheumatic disease remain unclear

Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more encouraging news for people living with rheumatic disease.

Data on potential risks of COVID-19 in psoriasis patients limited, but reassuring

For patients with psoriasis concerned about their outcome if infected with COVID-19, “there is no evidence to support stopping biologics or systemic agents.”

Identifying pancreatitis etiology may help prevent progression

Potential etiology of acute pancreatitis in 2020 includes genetic factors, drugs, and comorbidities.

Dr. Brian Mandell gives his take on ACR’s newest gout guideline

New guideline articulates a broad approach to treatment that needs to be tailored to individual patients.

Identify the dominant symptom in IBS

Many patients with irritable bowel syndrome don’t seek care. When they do, discuss time lines and triggers.

Identifying pancreatitis etiology may help prevent progression

Potential etiology of acute pancreatitis in 2020 includes genetic factors, drugs, and comorbidities.

Address root causes to manage NASH

Treat underlying factors such as obesity and diabetes to reduce risk of liver disease progression.

Reassuring rheumatic disease patients on value of bisphosphonates

Dr. Marcy B. Bolster addresses common patient concerns about bisphosphonate use.

Pages